Cargando…

Progression of Kidney Disease in Non-Diabetic Patients with Coronary Artery Disease: Predictive Role of Circulating Matrix Metalloproteinase-2, -3, and -9

BACKGROUND: Circulating matrix metalloproteinase (MMP)-2, -3 and -9 are well recognized in predicting cardiovascular outcome in coronary artery disease (CAD), but their risks for chronic kidney disease (CKD) are lacking. Therefore, the present study aimed to investigate whether circulating MMP level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Ta-Wei, Kuo, Ko-Lin, Hung, Szu-Chun, Huang, Po-Hsun, Chen, Jaw-Wen, Tarng, Der-Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724836/ https://www.ncbi.nlm.nih.gov/pubmed/23922934 http://dx.doi.org/10.1371/journal.pone.0070132

Ejemplares similares

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies
por: Hung, Szu-Chun, et al.
Publicado: (2015)

Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis
por: Kuo, Ko-Lin, et al.
Publicado: (2015)

Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease
por: Kuo, Ho-Chang, et al.
Publicado: (2017)

Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease
por: Kuo, Ko-Lin, et al.
Publicado: (2017)

Association of Fluid Retention With Anemia and Clinical Outcomes Among Patients With Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2015)

Granulocyte Colony-Stimulating Factor Improves Endothelial Progenitor Cell-Mediated Neovascularization in Mice with Chronic Kidney Disease
por: Tang, Shao-Yu, et al.
Publicado: (2023)

Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access
por: Wu, Chih-Cheng, et al.
Publicado: (2017)

Enhancement of matrix metalloproteinases 2 and 9 accompanied with neurogenesis following collagen glycosaminoglycan matrix implantation after surgical brain injury
por: Hsu, Wei-Cherng, et al.
Publicado: (2018)

Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020)

MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation
por: Shih, Yu-Chung, et al.
Publicado: (2021)

Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study
por: Chen, Yu-Hsin, et al.
Publicado: (2015)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Iron Therapy in Chronic Kidney Disease: Days of Future Past
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Matrix metalloproteinases in coronary artery disease and myocardial infarction
por: Bräuninger, Hanna, et al.
Publicado: (2023)

Call for Consensus in the Evaluation of Circulating Matrix Metalloproteinases in Chagas Disease
por: Bautista-López, Norma L., et al.
Publicado: (2022)

Circulating Matrix Metalloproteinase-2 and -9 Enzyme Activities in the Children with Ventricular Septal Defect
por: Cheng, Kun-Shan, et al.
Publicado: (2013)

Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases
por: Tsai, Shih-Hung, et al.
Publicado: (2016)

The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases
por: Liu, Zhao, et al.
Publicado: (2020)

Matrix Metalloproteinase-10 in Kidney Injury Repair and Disease
por: Sun, Xiaoli, et al.
Publicado: (2022)

Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma
por: Huang, Chien-Chia, et al.
Publicado: (2019)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Impact of Matrix Metalloproteinase-9 during Periodontitis and Cardiovascular Diseases
por: Isola, Gaetano, et al.
Publicado: (2021)

Correlation between genetic polymorphism of matrix metalloproteinase-9 in patients with coronary artery disease and cardiac remodeling
por: Yu, Qibin, et al.
Publicado: (2015)

Relationship between Circulating Serpina3g, Matrix Metalloproteinase-9, and Tissue Inhibitor of Metalloproteinase-1 and -2 with Chronic Obstructive Pulmonary Disease Severity
por: Uysal, Pelin, et al.
Publicado: (2019)

Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery Disease
por: Springall, Rashidi, et al.
Publicado: (2013)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis
por: Wang, Ling-Feng, et al.
Publicado: (2010)

Significance of Circulating and Crevicular Matrix Metalloproteinase-9 in Rheumatoid Arthritis-Chronic Periodontitis Association
por: Silosi, Isabela, et al.
Publicado: (2015)

Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke
por: Chen, Chun‐Yu, et al.
Publicado: (2020)

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease
por: Provatopoulou, Xeni, et al.
Publicado: (2009)

Matrix metalloproteinases in arthritic disease
por: Murphy, Gillian, et al.
Publicado: (2002)

Matrix Metalloproteinases in Health and Disease
por: Serra, Raffaele
Publicado: (2020)

Matrix metalloproteinase −2, −9 and arterial stiffness in children and adolescents: The role of chronic kidney disease, diabetes, and hypertension
por: Stabouli, Stella, et al.
Publicado: (2020)

Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease
por: Wu, Chia-Lin, et al.
Publicado: (2020)

Matrix Metalloproteinases-7 and Kidney Fibrosis
por: Ke, Ben, et al.
Publicado: (2017)

Phorbol ester-induced angiogenesis of endothelial progenitor cells: The role of NADPH oxidase-mediated, redox-related matrix metalloproteinase pathways
por: Wu, Tao-Cheng, et al.
Publicado: (2019)

Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease
por: Mahmoodi, Khalil, et al.
Publicado: (2017)

Molecular interactions of tannic acid and matrix metalloproteinases 2 and 9
por: Chiang, Ya-Tang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rld0l0mch1ka7oka7r8sfg0tp9